The FDA gives emergency authorization to treat coronavirus patients with convalescent plasma. Early studies of it have shown promise.
The US Food and Drug Administration issued an emergency use authorization for the use of convalescent plasma to treat Covid-19 on Sunday, saying the"known and potential benefits of the product outweigh the known and potential risks of the product."
The FDA said more than 70,000 patients had been treated convalescent plasma, made using the blood of people who have recovered from coronavirus infections."Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives," President Trump said at a White House briefing."Today's action will dramatically increase access to this treatment.
Her team counted 162 prospective studies and several more observational studies, but she said only six met the standard that could produce actionable results. There is no randomized clinical trial data yet, she said, but some of those trials are ongoing."We continue to have hints that this is an effective treatment in this particular virus," Woodcock said, adding that the NIH will initiate or boost additional trials to find out for sure, she said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump repeats chloroquine COVID-19 claims, accuses FDA of sabotaging vaccine trialsU.S. President Donald Trump suggested that the 'deep state' at the FDA deliberately delayed developing a COVID-19 vaccine.
Read more »
The FDA Authorized The Use Of Convalescent Plasma To Treat COVID-19Scientists say plasma collected from the blood of patients who have recovered from COVID-19 may be beneficial, but rigorous trials have not yet proven that it’s an effective treatment.
Read more »
FDA Authorizes Convalescent Plasma for Covid-19 UseThe emergency-use authorization comes after preliminary studies supported the benefits of the antibody-rich plasma taken from recovered Covid-19 patients.
Read more »
FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19President Trump announced that the Food and Drug Administration granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on 'promising' results.
Read more »
Trump and FDA announce new method to treat hospitalized COVID-19 patientsThe president said the new, expedited method of treatment has led to a reduced mortality rate by 35 percent in coronavirus patients.
Read more »
Trump announces emergency authorization for COVID-19 treatment after accusing FDA of delaysPresident Trump announces his admin. is providing an emergency use authorization for convalescent plasma to treat COVID-19, a treatment that more than 70,000 patients have already received.
Read more »